secwatch.observer — SEC 8-K summary
======================================

Issuer:     PATTERSON COMPANIES, INC. (—)
CIK:        0000891024
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001193125-25-087961
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Patterson Companies completes acquisition by Patient Square Capital; CEO Rajalingam appointed
--------------------------------------------------------------------------------

- Acquisition by Patient Square Capital closed April 17, 2025; Patterson common stock delisted from NASDAQ.
- Robert Rajalingam appointed CEO effective April 17, replacing Don Zurbay who retired and will support transition.
- Rajalingam was President of Cardinal Health's US Medical Products and Distribution since 2021, leading transformation.
- Patterson headquarters remains in St. Paul, Minnesota.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/891024/000119312525087961/0001193125-25-087961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/891024/000119312525087961/d913697d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-087961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer